To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data

Evaluation and the Health Professions

Volumn 25, Issue 1, 2002, Pages 76-97

  Stewart, Lesley A ^a   Tierney, Jayne F ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; INTERNATIONAL COOPERATION; METHODOLOGY; PATIENT CODING; QUALITY CONTROL; REVIEW; STANDARD;

DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DATABASES, BIBLIOGRAPHIC; HUMANS; INTERNATIONAL COOPERATION; META-ANALYSIS; REVIEW LITERATURE;

EID: 0036167948     PISSN: 01632787     EISSN: None     Source Type: Journal    
DOI: 10.1177/0163278702025001006     Document Type: Review

References (31)

1. Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials
2. Chemotherapy in advanced ovarian cancer: Four systematic meta-analyses of individual patient data from 37 randomised trials
3. Randomisation and baseline comparisons in clinical trials
4. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
5. The Cochrane Collaboration: Preparing, maintaining and disseminating systematic reviews of the effects of health care
6. The Cochrane Collaboration
7. Individual patient data meta-analyses in cancer
8. The existence of publication bias and risk factors for its occurrence
9. Factors influencing publication of research results
10. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
11. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy (Part 2)
12. Tamoxifen for early breast cancer: An overview of the randomised trials
13. Publication bias in clinical research
14. Laparoscopic compared with open methods of groin hernia repair - Systematic review of randomised controlled trials
15. Mesh compared with non-mesh methods of open groin hernia repair - Systematic review of randomised controlled trials
16. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: Meta-analyses of the randomised evidence
17. ICON2: Randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin and cisplatin) in women with ovarian cancer
18. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
19. Summing up the evidence: One answer is not always enough
20. Carbamazepine versus valproate monotherapy for epilepsy (Cochrane Review)
21. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
22. Meta-analyses of randomised trials: When the whole is more than just the sum of the parts
23. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
24. Postoperative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials
25. Cholinesterase inhibition of Alzheimer's disease: A meta-analysis of the tacrine trials
26. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
27. Practical methodology of meta-analyses (overviews) using updated individual patient data
28. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects
29. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?
30. Impact of covert duplicate publication on meta-analysis: A case study